Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13087-13094
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13087
Figure 4
Figure 4 Comparison of incidence of hepatocellular carcinoma in patients with chronic hepatitis B (A) and liver cirrhosis (B) between the lamivudine and control group. CHB: Chronic hepatitis B; LAM: Lamivudine.